» Articles » PMID: 22593613

An in Vivo IL-7 Requirement for Peripheral Foxp3+ Regulatory T Cell Homeostasis

Overview
Journal J Immunol
Date 2012 May 18
PMID 22593613
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

All T cells are dependent on IL-7 for their development and for homeostasis. Foxp3(+) regulatory T cells (Tregs) are unique among T cells in that they are dependent on IL-2. Whether such IL-2 dependency is distinct from or in addition to an IL-7 requirement has been a confounding issue, particularly because of the absence of an adequate experimental system to address this question. In this study, we present a novel in vivo mouse model where IL-2 expression is intact but IL-7 expression was geographically limited to the thymus. Consequently, IL-7 is not available in peripheral tissues. Such mice were generated by introducing a thymocyte-specific IL-7 transgene onto an IL-7 null background. In these mice, T cell development in the thymus, including Foxp3(+) Treg numbers, was completely restored, which correlates with the thymus-specific expression of transgenic IL-7. In peripheral cells, however, IL-7 expression was terminated, which resulted in a general paucity of T cells and a dramatic reduction of Foxp3(+) Treg numbers. Loss of Tregs was further accompanied by a significant reduction in Foxp3(+) expression levels. These data suggest that peripheral IL-7 is not only necessary for Treg survival but also for upregulating Foxp3 expression. Collectively, we assessed the effect of a selective peripheral IL-7 deficiency in the presence of a fully functional thymus, and we document a critical requirement for in vivo IL-7 in T cell maintenance and specifically in Foxp3(+) cell homeostasis.

Citing Articles

Altered characteristics of regulatory T cells in target tissues of Sjögren's syndrome in murine models.

Zhou J, Felix F, Jiang Y, Li D, Kim M, Jang D Mol Immunol. 2024; 174:47-56.

PMID: 39197397 PMC: 11500054. DOI: 10.1016/j.molimm.2024.08.003.


The ever-expanding role of cytokine receptor DR3 in T cells.

Liman N, Lanasa D, Meylan F, Park J Cytokine. 2024; 176:156540.

PMID: 38359559 PMC: 10895922. DOI: 10.1016/j.cyto.2024.156540.


IL-7-Treated Periodontal Ligament Cells Regulate Local Immune Homeostasis by Modulating Treg/Th17 Cell Polarization.

Yu X, Zhang Z, Huang J, Lin J, Cai X, Liu C Front Med (Lausanne). 2022; 9:754341.

PMID: 35280902 PMC: 8905254. DOI: 10.3389/fmed.2022.754341.


In vivo availability of the cytokine IL-7 constrains the survival and homeostasis of peripheral iNKT cells.

Park J, Won H, DiPalma D, Kim H, Kim T, Li C Cell Rep. 2022; 38(2):110219.

PMID: 35021100 PMC: 10292121. DOI: 10.1016/j.celrep.2021.110219.


Lymphopenia-induced lymphoproliferation drives activation of naive T cells and expansion of regulatory populations.

S E, Eldershaw S, Verma K, K V, W C, Croft W iScience. 2021; 24(3):102164.

PMID: 33665580 PMC: 7907823. DOI: 10.1016/j.isci.2021.102164.


References
1.
Bennett C, Christie J, Ramsdell F, Brunkow M, Ferguson P, Whitesell L . The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet. 2001; 27(1):20-1. DOI: 10.1038/83713. View

2.
Kim G, Hong C, Park J . Seeing is believing: illuminating the source of in vivo interleukin-7. Immune Netw. 2011; 11(1):1-10. PMC: 3072672. DOI: 10.4110/in.2011.11.1.1. View

3.
Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A . Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006; 203(7):1693-700. PMC: 2118333. DOI: 10.1084/jem.20060468. View

4.
Grabstein K, Waldschmidt T, Finkelman F, Hess B, Alpert A, Boiani N . Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J Exp Med. 1993; 178(1):257-64. PMC: 2191094. DOI: 10.1084/jem.178.1.257. View

5.
Sprent J, Surh C . Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat Immunol. 2011; 12(6):478-84. PMC: 3434123. DOI: 10.1038/ni.2018. View